COMPANY OVERVIEW

Werewolf Therapeutics is developing medicines designed to be delivered systemically, but remain inactive in the body until they reach the tumor microenvironment, where they stimulate a powerful immune response and unleash an attack on cancer cells.

---

LOCATION

Cambridge, MA, USA

---

THERAPEUTIC AREAS

Oncology

---

WEBSITE

https://werewolftx.com

---

CAREER WEBSITE

None

---

SOCIAL MEDIA

---

INVESTORS

---

---

PRESS RELEASES

Feb 8, 2021

Werewolf Therapeutics Appoints Tim Trost as Chief Financial Officer

Jan 7, 2021

Werewolf Therapeutics Completes $72 Million Series B Financing to Advance a Novel Class of Cancer Biotherapeutics to the Clinic

Nov 9, 2020

Werewolf Therapeutics Appoints Dr. Randi Isaacs as Chief Medical Officer

Aug 10, 2020

Werewolf Therapeutics Appoints Business Leader, Ellen Lubman, as Chief Business Officer

Nov 20, 2019

Werewolf Therapeutics Launches with $56M Series A Financing to Develop Transformative Immuno-Stimulatory Cancer Medicines

For More Press Releases

---